España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Regenxbio
RGNX
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$12.73
0.15
1.19%
Pre-Market: Jul 19, 4:11 PM EDT
15 minutes delayed
Get Report
Comment
Regenxbio (RGNX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Regenxbio (NASDAQ:RGNX) Stock
Regenxbio Stock (NASDAQ: RGNX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, June 25, 2024
Why Is Clearside Biomedical Stock Gaining Today?
Vandana Singh
Monday, June 24, 2024
REGENXBIO Expands Its AFFINITY DUCHENNE Trial...
Benzinga Newsdesk
Friday, June 21, 2024
FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy
Vandana Singh
Thursday, June 20, 2024
HC Wainwright & Co. Reiterates Buy on Regenxb...
Benzinga Newsdesk
Tuesday, June 18, 2024
Regenxbio Concludes Pre-biologics License App...
Benzinga Newsdesk
Monday, June 17, 2024
Urogen Pharma Surges 9.7%: Is This an Indication of Further Gains?
Zacks
Wednesday, June 12, 2024
Regenxbio Reiterated Its Financial Guidance P...
Benzinga Newsdesk
REGENXBIO Announced That Curran Simpson, Chie...
Benzinga Newsdesk
Friday, June 07, 2024
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
Vandana Singh
Assessing Regenxbio: Insights From 4 Financial Analysts
Benzinga Insights
Goldman Sachs Initiates Coverage On Regenxbio...
Benzinga Newsdesk
Wednesday, May 15, 2024
Evaluating Regenxbio: Insights From 9 Financial Analysts
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Regenxbi...
Benzinga Newsdesk
Wednesday, May 08, 2024
Regenxbio Q1 2024 GAAP EPS $(1.38) Misses $(1...
Benzinga Newsdesk
Friday, April 12, 2024
Where Regenxbio Stands With Analysts
Benzinga Insights
Stifel Maintains Buy on Regenxbio, Maintains ...
Benzinga Newsdesk
Thursday, March 28, 2024
REGENXBIO Announces Lancet Publication of Pha...
Benzinga Newsdesk
Monday, March 25, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Monday, March 11, 2024
HC Wainwright & Co. Initiates Coverage On Reg...
Benzinga Newsdesk
Friday, March 08, 2024
This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO
Vandana Singh
Regenxbio shares are trading higher after RBC...
Benzinga Newsdesk
RBC Capital Upgrades Regenxbio to Outperform,...
Benzinga Newsdesk
Thursday, March 07, 2024
Chardan Capital Maintains Buy on Regenxbio, M...
Benzinga Newsdesk
Barclays Maintains Overweight on Regenxbio, R...
Benzinga Newsdesk
REGENXBIO Prices Upsized Public Offering Of 4...
Benzinga Newsdesk
Wednesday, March 06, 2024
REGENXBIO Announces Proposed $125M Public Off...
Benzinga Newsdesk
Leerink Partners Upgrades Regenxbio to Outper...
Benzinga Newsdesk
Beyond The Numbers: 4 Analysts Discuss Regenxbio Stock
Benzinga Insights
Baird Maintains Outperform on Regenxbio, Rais...
Benzinga Newsdesk
Tuesday, March 05, 2024
REGENXBIO's Muscle Wasting Disorder Drug Shows Strength, Improved Motor Function, Stock Soars
Vandana Singh
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
REGENXBIO shares are trading higher after the...
Benzinga Newsdesk
Regenxbio Announces New Initial Efficacy Data...
Benzinga Newsdesk
Friday, March 01, 2024
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Wednesday, February 28, 2024
Wedbush Reiterates Neutral on Regenxbio, Main...
Benzinga Newsdesk
Tuesday, February 27, 2024
REGENXBIO Expects Its Balance In Cash & Equiv...
Benzinga Newsdesk
Regenxbio: Q4 Earnings Insights
Benzinga Insights
Regenxbio Q4 2023 GAAP EPS $(1.43) Misses $(1...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2024
Benzinga Insights
Monday, February 26, 2024
A Preview Of Regenxbio's Earnings
Benzinga Insights
Wednesday, February 21, 2024
Raymond James Reinstates Outperform on Regenx...
Benzinga Newsdesk
Monday, February 12, 2024
Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst
Vandana Singh
Wedbush Reiterates Neutral on Regenxbio, Main...
Benzinga Newsdesk
Friday, February 09, 2024
Jim Cramer Says Investors Should Look Beyond Apple, Meta And Other Magnificent 7 Stocks: 'You Might Be Missing Out On Some Huge Gains'
Benzinga Neuro
Thursday, February 08, 2024
Why Is Blindness Focused-Adverum Biotechnologies Stock Trading Lower Today?
Vandana Singh
Wednesday, February 07, 2024
Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Why Is Gene Therapy-Focused REGENXBIO Stock Trading Higher Today?
Vandana Singh
REGENXBIO shares are trading higher after the...
Benzinga Newsdesk
REGENXBIO Says As Of January 3, 2024, RGX-121...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
